Tissue-Based Biomarkers Important for Prognostication and Management of Genitourinary Tumors, Including Surrogate Markers of Genomic Alterations
Surgical Pathology Clinics · 2025
DOI: 10.1016/j.path.2024.10.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Surgical Pathology Clinics, 2025. Verfasst von Leonie Beauchamp und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Urogenital Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 116 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.
- Departments of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA; Department of Urology, The Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA; Department of Oncology, The Johns Hopk…
Zitieren
APA
Beauchamp, L., Indulkar, S., Erak, E., Salimian, M., & Matoso, A. (2025). Tissue-Based Biomarkers Important for Prognostication and Management of Genitourinary Tumors, Including Surrogate Markers of Genomic Alterations. Surgical Pathology Clinics. https://doi.org/10.1016/j.path.2024.10.002
Vancouver
Beauchamp L, Indulkar S, Erak E, Salimian M, Matoso A. Tissue-Based Biomarkers Important for Prognostication and Management of Genitourinary Tumors, Including Surrogate Markers of Genomic Alterations. Surgical Pathology Clinics. 2025. doi:10.1016/j.path.2024.10.002
BibTeX
@article{Beauchamp2025,
author = {Beauchamp, Leonie and Indulkar, Shreeya and Erak, Eric and Salimian, Mohammad and Matoso, Andres},
title = {Tissue-Based Biomarkers Important for Prognostication and Management of Genitourinary Tumors, Including Surrogate Markers of Genomic Alterations},
journal = {Surgical Pathology Clinics},
year = {2025},
doi = {10.1016/j.path.2024.10.002}
}
EUVIMED